Rubegni Giovanni, Zeppieri Marco, Tognetti Linda, Cinotti Elisa, De Piano Ernesto, D'Onghia Martina, Orione Matteo, Gagliano Caterina, Bacci Tommaso, Tarantello Antonio, Lo Russo Nicola, Castellino Niccolò, Miranda Giusy, Cartocci Alessandra, Tosi Gian Marco, Avitabile Teresio
Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.
J Clin Med. 2024 Aug 14;13(16):4787. doi: 10.3390/jcm13164787.
Lentigo maligna (LM) and lentigo maligna melanoma (LMM) are significant subtypes of melanoma, with an annual incidence of 1.37 per 100,000 people in the U.S. These skin tumors, often found in photo-exposed areas such as the face, are frequently misdiagnosed, leading to delayed treatment or unnecessary excisions, especially in the elderly. Facial melanocytic skin tumors (lentigo maligna-LM/lentigo maligna melanoma-LMM) and their simulators (solar lentigo, pigmented actinic keratosis, seborrheic keratosis and lichen planus-like keratosis) often affect the periocular region. Thus, their diagnosis and management can involve different medical figures, mainly dermatologists and ophthalmologists. This study aimed to evaluate the ability of ophthalmologists to diagnose and manage pigmented skin lesions of the periorbital area. : A multicentric, retrospective, cross-sectional study on a dataset of 79 periorbital pigmented skin lesions with both clinical and dermoscopic images was selected. The images were reviewed by six ophthalmologists and two dermatologists. Descriptive statistics were carried out, and the accuracy, sensitivity, and specificity, with their 95% confidence interval (95% CI), were estimated. Ophthalmologists achieved a diagnostic accuracy of 63.50% (95% CI: 58.99-67.85%), while dermatologists achieved 66.50% (95% CI: 58.5-73.8). The sensitivity was lower for ophthalmologists in respect to dermatologists, 33.3% vs. 46.9%, respectively. Concerning the case difficulty rating, ophthalmologists rated as "difficult" 84% of cases, while for dermatologists, it was about 30%. Management was also consistently different, with a "biopsy" decision being suggested in 25.5% of malignant lesions by ophthalmologists compared with 50% of dermatologists. Ophthalmologists revealed a good diagnostic potential in the identification of periorbital LMs/LMMs. Given progressive population ageing and the parallel increase in facial/periorbital skin tumors, the opportunity to train new generations of ophthalmologists in the early diagnosis of these neoformations should be considered in the next future, also taking into account the surgical difficulty/complexity of this peculiar facial area.
恶性雀斑样痣(LM)和恶性雀斑样痣黑色素瘤(LMM)是黑色素瘤的重要亚型,在美国每10万人中的年发病率为1.37。这些皮肤肿瘤常出现在面部等暴露于阳光下的部位,经常被误诊,导致治疗延迟或不必要的切除,尤其是在老年人中。面部黑素细胞性皮肤肿瘤(恶性雀斑样痣-LM/恶性雀斑样痣黑色素瘤-LMM)及其模拟物(日光性雀斑、色素性光化性角化病、脂溢性角化病和扁平苔藓样角化病)常累及眼周区域。因此,它们的诊断和管理可能涉及不同的医学专业人员,主要是皮肤科医生和眼科医生。本研究旨在评估眼科医生诊断和管理眶周色素性皮肤病变的能力。:对一个包含79例眶周色素性皮肤病变的数据集进行了一项多中心、回顾性、横断面研究,该数据集同时包含临床和皮肤镜图像。六名眼科医生和两名皮肤科医生对这些图像进行了评估。进行了描述性统计,并估计了准确性、敏感性和特异性及其95%置信区间(95%CI)。眼科医生的诊断准确率为63.50%(95%CI:58.99-67.85%),而皮肤科医生为66.50%(95%CI:58.5-73.8)。眼科医生的敏感性低于皮肤科医生,分别为33.3%和46.9%。关于病例难度评级,眼科医生将84%的病例评为“困难”,而皮肤科医生约为30%。管理方式也始终不同,眼科医生建议对25.5%的恶性病变进行“活检”,而皮肤科医生为50%。眼科医生在识别眶周LM/LMM方面显示出良好的诊断潜力。鉴于人口老龄化的加剧以及面部/眶周皮肤肿瘤的相应增加,在未来应考虑为新一代眼科医生提供这些新形成病变早期诊断方面的培训机会,同时也要考虑到这个特殊面部区域手术难度/复杂性。